A Study of [14C]-LY4064809 in Healthy Participants

NCT07519525 · clinicaltrials.gov ↗

PHASE1

Phase

RECRUITING

Status

8

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy

Interventions

DRUG: LY4064809
DRUG: [14C]-LY4064809

Sponsor

Eli Lilly and Company